Lung Cancer News and Research

Latest Lung Cancer News and Research

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

1 Dec 2009

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

New figures show there was a steady decline in cancer deaths in the European Union between 1990-1994 and 2000-2004.

1 Dec 2009

Cancer patient's chances of surviving for at least a year varies depending on where they live

CANCER RESEARCH UK is calling on the government and PCTs across the country to act urgently after shocking new figures, out today (Tuesday), reveal a cancer patient's chances of surviving for at least a year varies hugely depending on where they live.

1 Dec 2009

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

Researchers from VU University Medical Center in Amsterdam have reported that RapidArc® radiotherapy from Varian Medical Systems has clinical advantages over earlier fixed-beam approaches to stereotactic treatments of lung tumors. Their findings, based on treatment of 85 medically inoperable lung cancer patients, were reported at the recent annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago and a condensed version has been published in the 'Green Journal' (Radiotherapy and Oncology) 93 (2009).

1 Dec 2009

BioMarin Pharmaceutical receives FDA orphan drug designation for 3,4-DAP

BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.

30 Nov 2009

HPS offers recommendations against potential risks caused by radon in indoor environment

Radon is a colorless and odorless radioactive gas that is produced by the radioactive decay of radium. Radium is a product of uranium decay and is found in trace amounts naturally in nearly all rocks, soils, and groundwater as well as building materials, plants, animals, and the human body.

30 Nov 2009

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 29 to December 3 at McCormick Place in Chicago, Siemens Healthcare will introduce its comprehensive portfolio for imaging in interventional oncology at booth #825, East Building/Lakeside Center, Hall D.

30 Nov 2009

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.

30 Nov 2009

Study on deaths from cancer in Europe shows steady decline in mortality

New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union (EU) between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population.

29 Nov 2009

LCA-CA issues 2nd Annual Report Card on Lung Cancer

Today, Lung Cancer Alliance-California (LCA-CA) issued its 2nd Annual Report Card on Lung Cancer. The 2009 Report Card is an assessment of progress being made against this lethal disease in the state of California.

26 Nov 2009

LCA-GA issues 4th Annual Report Card on Lung Cancer

Today, Lung Cancer Alliance-Georgia (LCA-GA) issued the 4th Annual Report Card on Lung Cancer. This Report is an assessment of progress being made against this lethal disease in the state of Georgia.

26 Nov 2009

Smoothie Factory supports Chronic Disease Fund’s mission with holiday fundraising program

More than 14-million Americans, with chronic or life altering diseases and cancer, can’t afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That’s why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.

25 Nov 2009

'Suicide gene E' reduces potent drug dosage in cancer patients

Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.

25 Nov 2009

Study may pave way for potential drug targets in lung cancer treatment

Researchers from Boston University School of Medicine (BUSM) and the Boston University Biomedical Engineering Department have identified a number of proteins whose activation allows them to distinguish between cancer and normal cells with almost 97 percent accuracy.

25 Nov 2009

Study: GSTP gene protects against bowel cancer

CANCER RESEARCH UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.

25 Nov 2009

Clavis Pharma signs drug development and commercialisation agreement with Clovis Oncology

Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.

24 Nov 2009

LCA-NY issues 2009 Report Card on Lung Cancer

Today, Lung Cancer Alliance-New York (LCA-NY) issued its 1st Report Card on Lung Cancer. This Report is an assessment of progress being made against lung cancer in the state of New York. LCA-NY is a chapter of Lung Cancer Alliance (LCA), the only national organization dedicated exclusively to patient support and advocacy for people living with or at risk for lung cancer.

23 Nov 2009

Alcohol consumption in pregnancy affects child behaviour in different ways: Study

A new study from Perth's Telethon Institute for Child Health Research has found evidence that the amount and timing of alcohol consumption in pregnancy affects child behaviour in different ways.

23 Nov 2009

Positive interim results from Nereus Pharmaceuticals' plinabulin VDA study for advanced NSCLC

Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).

23 Nov 2009

Medical report showing the devastating impacts of coal on human body released

Physicians for Social Responsibility today released a groundbreaking medical report, "Coal's Assault on Human Health," which takes a new look at the devastating impacts of coal on the human body.

23 Nov 2009

Lung Cancer News and Research

Latest Lung Cancer News and Research

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

Cancer patient's chances of surviving for at least a year varies depending on where they live

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

BioMarin Pharmaceutical receives FDA orphan drug designation for 3,4-DAP

HPS offers recommendations against potential risks caused by radon in indoor environment

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

Study on deaths from cancer in Europe shows steady decline in mortality

LCA-CA issues 2nd Annual Report Card on Lung Cancer

LCA-GA issues 4th Annual Report Card on Lung Cancer

Smoothie Factory supports Chronic Disease Fund’s mission with holiday fundraising program

'Suicide gene E' reduces potent drug dosage in cancer patients

Study may pave way for potential drug targets in lung cancer treatment

Study: GSTP gene protects against bowel cancer

Clavis Pharma signs drug development and commercialisation agreement with Clovis Oncology

LCA-NY issues 2009 Report Card on Lung Cancer

Alcohol consumption in pregnancy affects child behaviour in different ways: Study

Positive interim results from Nereus Pharmaceuticals' plinabulin VDA study for advanced NSCLC

Medical report showing the devastating impacts of coal on human body released

The ultimate guide to lung research tools and protocols eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in